Koers Alternate Health Corp. Canadian Securities Exchange
Aandelen
AHG
CA02090B1022
Farmaceutische producten
Omzet 2017 | 13,25 mln. 9,68 mln. 8,86 mln. | Omzet 2018 | 577K 422K 386K | Marktkapitalisatie | 22,67 mln. 16,56 mln. 15,15 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2017 | -26 mln. -19 mln. -17,37 mln. | Nettowinst (verlies) 2018 | -24 mln. -17,54 mln. -16,04 mln. | EV/omzet 2017 | 6,25 x |
Nettoliquiditeiten 2017 | 893K 652K 596K | Nettoliquiditeiten 2018 | 773K 564K 516K | EV/omzet 2018 | 37,9 x |
K/w-verhouding 2017 |
-3,04
x | K/w-verhouding 2018 |
-0,76
x | Werknemers | - |
Dividendrendement 2017 * |
-
| Dividendrendement 2018 |
-
| Vrij verhandelbaar | 100% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Howard Mann
FOU | Founder | - | 11-12-18 |
Director of Finance/CFO | - | 25-01-18 | |
Chairman | - | 05-04-17 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
James E. Tykoliz
BRD | Director/Board Member | - | 16-04-15 |
Chairman | - | 05-04-17 | |
Howard Mann
FOU | Founder | - | 11-12-18 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+7,30% | 4,81 mld. | |
-31,08% | 3,6 mld. | |
-0,71% | 3,09 mld. | |
-24,32% | 2,62 mld. | |
-11,35% | 2,27 mld. | |
+34,19% | 1,82 mld. | |
+33,49% | 1,41 mld. | |
-15,07% | 1,38 mld. | |
+40,95% | 1,37 mld. |